Johnson & Johnson vs Legend Biotech Corporation — Stock Comparison
Q·Score Breakdown
7.1
Bullish
Overall
5.9
Neutral
Quality
Health
Growth
Valuation
Sentiment
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
LEGN
Consensus analyst target of $57.23 is 143% above current price.
⚠ currently unprofitable (-29% margin).
Analyst Consensus
BUY
Target $252.42 (+11.1%)
24 analysts
BUY
Target $57.23 (+142.6%)
16 analysts
Fundamentals
JNJ
LEGN
26.3×
Trailing P/E
—
17.9×
Forward P/E
20.5×
21.8%
Profit Margin
-28.8%
68.0%
Gross Margin
20.0%
26.4%
ROE
-29.1%
9.9%
Revenue Growth
64.2%
-52.9%
Earnings Growth
—
0.33
Beta
0.08
—
Price / Book
—
$546.9B
Market Cap
$4.4B
$146 – $252
52-Week Range
$16 – $45
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →